Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Tenon Medical, Inc. (TNON : NSDQ)

• Company Description    Tenon Medical Inc. is a medical device company which developed a proprietary, U.S. Food and Drug Administration cleared surgical implant system for sacroiliac joint fixation/fusion surgery. Tenon Medical Inc. is based in LOS GATOS, CA. Number of Employees: 27

• Price / Volume Information    Yesterday's Closing Price: $0.95 Daily Weekly Monthly 20 Day Moving Average: 72,819 shares Shares Outstanding: 11.11 (millions) Market Capitalization: $10.57 (millions) Beta: 1.28 52 Week High: $5.85 52 Week Low: $0.85 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -15.80% -15.65% 12 Week -20.04% -21.33% Year To Date 0.00% 0.00%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 104 COOPER COURT - LOS GATOS,CA 95032 USA ph: 408-649-5760 fax: - tenon@mzgroup.us http://www.tenonmed.com

• General Corporate Information    Officers Steven M. Foster - Chief Executive Officer; President and Director Richard Ferrari - Executive Chairman Kevin Williamson - Chief Financial Officer Richard Ginn - Chief Technology Officer and Director Ivan Howard - Director Peer Information Tenon Medical, Inc. (ABMD) Tenon Medical, Inc. (DMDS) Tenon Medical, Inc. (CPWY.) Tenon Medical, Inc. (EQUR) Tenon Medical, Inc. (ECIA) Tenon Medical, Inc. (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 88066N303 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 03/19/26 Share - Related Items Shares Outstanding: 11.11 Most Recent Split Date: 9.00 (0.13:1) Beta: 1.28 Market Capitalization: $10.57 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 03/19/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 4.90 Price/Cash Flow: - Price / Sales: 3.27 EPS Growth vs. Year Ago Period: 88.98% vs. Previous Quarter: -11.11% Sales Growth vs. Year Ago Period: 32.24% vs. Previous Quarter: 107.98% ROE 12/31/25 - - 09/30/25 - -409.04 06/30/25 - -332.11 ROA 12/31/25 - - 09/30/25 - -114.60 06/30/25 - -106.82 Current Ratio 12/31/25 - - 09/30/25 - 2.15 06/30/25 - 3.86 Quick Ratio 12/31/25 - - 09/30/25 - 1.70 06/30/25 - 3.59 Operating Margin 12/31/25 - - 09/30/25 - -396.26 06/30/25 - -429.45 Net Margin 12/31/25 - - 09/30/25 - -396.26 06/30/25 - -429.45 Pre-Tax Margin 12/31/25 - - 09/30/25 - -396.26 06/30/25 - -429.45 Book Value 12/31/25 - - 09/30/25 - 0.19 06/30/25 - 0.39 Inventory Turnover 12/31/25 - - 09/30/25 - 1.89 06/30/25 - 2.56 Debt-to-Equity 12/31/25 - - 09/30/25 - 0.00 06/30/25 - 0.00 Debt-to-Capital 12/31/25 - - 09/30/25 - 0.00 06/30/25 - 0.00

Powered by Zacks Investment Research ©